Abstract:Background: Laryngeal cancer is one of the most common malignant tumors among head and neck cancers. Accumulating studies have indicated that long noncoding RNAs (lncRNAs) play an important role in laryngeal cancer occurrence and progression, however, the functional roles and relative regulatory mechanisms of lncRNA growth arrest-specific transcript 5 (GAS5) in laryngeal cancer progression remain unclear. Methods: The expression of lncRNA GAS5 in both laryngeal cancer tissues and cell lines was evaluated using quantitative reverse transcription-polymerase chain reaction (RT-qPCR) assay. The relationships between lncRNA GAS5 expression and clinical parameters were also analyzed. To determine the biological function of lncRNA GAS5, a lncRNA GAS5-specific plasmid was first transfected into laryngeal cancer cells using lentiviral technology. Cell counting kit-8 assay, flow cytometry, and Transwell assays were used to detect in vitro cell proliferation, apoptosis, cycle distribution, and metastasis abilities, respectively. Furthermore, in vivo cell growth experiments were also performed using nude mice. Additionally, western blotting was performed to identify the underlying regulatory mechanism. Results: In the current study, lncRNA GAS5 was downregulated in laryngeal cancer tissues and its low expression was closely associated with poor tumor differentiation, advanced TNM stage, lymph node metastasis, and shorter overall survival time. In addition, lncRNA GAS5 upregulation significantly inhibited laryngeal cancer cell proliferation both in vitro and in vivo. Moreover, in response to lncRNA GAS5 overexpression, more laryngeal cancer cells were arrested at the G2/M stage, accompanied by increased cell apoptosis rates and suppressed migration and invasion capacities. Mechanistically, our data showed that the overexpression of lncRNA GAS5 significantly regulated the PI3K/AKT/mTOR signaling pathway. Conclusion: LncRNA GAS5 might act as a suppressor gene during laryngeal cancer development, as it suppressed cell proliferation and metastasis by regulating the PI3K/AKT/mTOR signaling pathway; thus, lncRNA GAS5 is a promising therapeutic biomarker for the treatment of laryngeal cancer.

LncRNA GAS5 represses stemness and malignancy of gliomas via elevating the SPACA6-miR-125a/let-7e Axis

GAS5 Suppresses Malignancy of Human Glioma Stem Cells via a miR-196a-5p/FOXO1 feedback loop.

Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting Mir-222

LncRNA GAS5 Regulates the Wnt/β-catenin Pathway Through the Mir-18A-5p/axin2/gsk3β Axis to Inhibit the Proliferation and Migration of Bladder Cancer Cells.

A Critical Role for the Long Non‐coding RNA GAS5 in Proliferation and Apoptosis in Non‐small‐cell Lung Cancer

Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway

Long non-coding RNA GAS5 in human cancer

The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers

Long Non-Coding RNA CASP5 Promotes the Malignant Phenotypes of Human Glioblastoma Multiforme.

Negative regulation of lncRNA GAS5 by miR-196a inhibits esophageal squamous cell carcinoma growth

The role of long non-coding RNA GAS5 in cancers

Long Non-Coding RNA GAS5 Inhibits Cell Proliferation, Induces G0/G1 Arrest and Apoptosis, and Functions As a Prognostic Marker in Colorectal Cancer.

LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing SOX2 expression

Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6

Downregulation Of Gas5 Promotes Bladder Cancer Cell Proliferation, Partly By Regulating Cdk6

Long Non-Coding RNA-GAS5 Acts As a Tumor Suppressor in Bladder Transitional Cell Carcinoma Via Regulation of Chemokine (C-C Motif) Ligand 1 Expression

Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer

Integrated Analysis Reveals Prognostic Value and Mesenchymal Identity Suppression by Glycoprotein M6B in Glioma.

FGD5-AS1 Facilitates Glioblastoma Progression by Activation of Wnt/β-catenin Signaling Via Regulating Mir-129-5p/hnrnpk Axis

LncRNA DGCR5 plays a tumor-suppressive role in glioma via the miR-21/Smad7 and miR-23a/PTEN axes

SIRT5 Downregulation is Associated with Poor Prognosis in Glioblastoma